Similar articles

• Plasmapheresis in patients with leukaemia, multiple myeloma and immune complex diseases.

  Mód A, Füst G, Harsányi V, Natonek K, Poros A, Szabó J, Hollán SR. Mód A, et al. Haematologia (Budap). 1981;14(1):49-56. Haematologia (Budap). 1981. PMID: 6454615
• Plasmapheresis--bloodletting revived and refined.

  Waldenström JG. Waldenström JG. Acta Med Scand. 1980;208(1-2):1-4. Acta Med Scand. 1980. PMID: 6449137 No abstract available.
• What are the established clinical indications for therapeutic plasma exchange and how important is the choice of replacement fluid for efficacy of therapeutic plasma exchange in these situations?

  [No authors listed] [No authors listed] Vox Sang. 1982 Nov;43(5):270-95. Vox Sang. 1982. PMID: 6216664 No abstract available.
• [Objectives and methods of plasmapheresis in its therapeutic use].

  Boroń P, Miegoć H, Prokopowicz D. Boroń P, et al. Pol Tyg Lek. 1987 Sep 28;42(39):1232-3. Pol Tyg Lek. 1987. PMID: 2964002 Review. Polish. No abstract available.
• The role of therapeutic plasmapheresis in the rheumatic diseases.

  Jones JV, Clough JD, Klinenberg JR, Davis P. Jones JV, et al. J Lab Clin Med. 1981 May;97(5):589-98. J Lab Clin Med. 1981. PMID: 6452484 Review. No abstract available.